Publicacións en colaboración con investigadores/as de Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (12)

2023

  1. Transfusion practice in patients receiving VV ECMO (PROTECMO): a prospective, multicentre, observational study

    The Lancet Respiratory Medicine, Vol. 11, Núm. 3, pp. 245-255

2019

  1. Imbalance in the Expression of Genes Associated with Purinergic Signalling in the Lung and Systemic Arteries of COPD Patients

    Scientific Reports, Vol. 9, Núm. 1

  2. The use of ECMO in ICU. Recommendations of the Spanish Society of Critical Care Medicine and Coronary Units

    Medicina Intensiva, Vol. 43, Núm. 2, pp. 108-120

2018

  1. Defining the role of neutrophil-to-lymphocyte ratio in COPD: A systematic literature review

    International Journal of COPD, Vol. 13, pp. 3651-3662

  2. Impact of acute exacerbations on platelet reactivity in chronic obstructive pulmonary disease patients

    International Journal of COPD, Vol. 13, pp. 141-148

  3. Is the purinergic pathway involved in the pathology of COPD? Decreased lung CD39 expression at initial stages of COPD

    Respiratory Research, Vol. 19, Núm. 1

2017

  1. Effectiveness of a Respiratory Day Hospital Program to Reduce Admissions for Exacerbation in Patients with Severe COPD: A Prospective, Multicenter Study

    COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol. 14, Núm. 3, pp. 304-310

  2. Vascular disease in COPD: Systemic and pulmonary expression of PARC (Pulmonary and Activation-Regulated Chemokine)

    PLoS ONE, Vol. 12, Núm. 5

2016

  1. Systemic and pulmonary vascular remodelling in chronic obstructive pulmonary disease

    PLoS ONE, Vol. 11, Núm. 4

  2. Treatment of patients with COPD and recurrent exacerbations: The role of infection and inflammation

    International Journal of COPD, Vol. 11, Núm. 1, pp. 515-525

2015

  1. Gene and Protein Expression of Fibronectin and Tenascin-C in Lung Samples from COPD Patients

    Lung, Vol. 193, Núm. 3, pp. 335-343

  2. Roflumilast added to triple therapy in patients with severe COPD: A real life study

    Pulmonary Pharmacology and Therapeutics, Vol. 30, pp. 16-21